-
Study aim
-
Comparison of the effectiveness of atropine-neostigmine mixture injection and ondansetron injection in preventing headache after cesarean section under spinal anesthesia
-
Design
-
A clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 60 patients. Lottery and sealed envelopes are used for randomization.
-
Settings and conduct
-
This is a randomized double-blind clinical trial that will be performed on 60 patients undergoing cesarean section under spinal anesthesia at Beheshti Hospital in Isfahan; After the approval of the university ethics committee and obtaining the patients' consent, the patients entered the groups by random allocation. In each group, the desired intervention is applied and the patient's clinical signs and existing complications are reviewed and recorded. The person who is performing the intervention would be different from the evaluator and they do not know the type of intervention. In spite of the fact that Patients are aware of the study, they are not aware of the type of intervention so they are all blind.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 18 to 45 years old pregnant woman undergoing cesarean section under spinal anesthesia, anesthesia ASA class I and II, and patient informed consent. Exclusion criteria: history of coagulation diseases, presence of nerve damage in limbs, spine, and CNS, history of spinal surgery, MS, and Migraine history.
-
Intervention groups
-
Intervention group A: They receive a mixture containing 20 µg/kg Neostigmine and 10µg/kg Atropine 15 minutes before the spinal anesthesia.
Intervention group B: They Receive 4 mg of ondansetron 15 minutes before spinal anesthesia.Control group C: They receive 5 ml of distilled water 15 minutes before the spinal.
-
Main outcome variables
-
The headache after spinal anesthesia